Login
Home / CMGMF : OTC
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis News Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Chemring Group PLC

$7.2 +$1.15 (+19.01%)
OTC · 14 Sep 2026 20:00 UTC
Previous Close
$7.2
Day Range
$7.2$8.59
Year Range
$5.95$8.59
Market Cap
1.95B
AVG Volume
891
Trailing/Forward PE
43.38/29.2
PEG ratio
1.93
Dividend Yield
1.53%
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (GBP)
0100M200M300M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Net Income (GBP)
-20M020M40M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Operating Income (GBP)
020M40M60M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
EBITDA (GBP)
020M40M60M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Cash Flows (GBP)
-40M-20M020M40M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
EPS (GBP)
-0.0500.050.121 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Expenses (GBP)
-100M0100M200M300M400MR&DSG&ACapex21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Cash & Debt (GBP)
050M100M150M200MCashLong Term DebtShort Term Debt21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Debt ratios
00.20.40.60.821 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Margins
0%25%50%75%100%21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Return on Capital
-5%0%5%10%21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Shares Outstanding
0100M200M300M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Dividends (GBP)
00.020.040.060.08Mar 22Aug 22Mar 23Aug 23Mar 24Aug 24Mar 25Aug 25Mar 26Aug 26
Book Value Per Share (GBP)
00.511.521 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Total Assets (GBP)
0250M500M750M1B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
PE Ratio
10203040med 25.41Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Free Cash Flow Yield
-2%0%2%4%6%med 1.13%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Sales
0.7511.251.51.75med 1.37Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
EV/EBITDA
4681012med 8.21Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price/Operating Cashflow
4681012med 8.71Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Book
2345med 3.66Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Chemring Group PLC
CMGMF
Stockpicker

Video analysis: CMGMF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: CMGMF

Defence sector rallies as Starmer confirms more spending on drones and nuclear deterrent

proactiveinvestors.co.uk · 30 Jun 2026

Defence sector rallies as Starmer confirms more spending on drones and nuclear deterrent

BAE Systems PLC (LSE:BA.), Chemring Group (LSE:CHG) and other UK defence stocks rallied after the government confirmed a £15 billion increase in military spending, with drones, ammunition stockpiles and the nuclear deterrent among the priorities.
Chemring wins $345m of contracts with US Dept of War for airborne countermeasures

proactiveinvestors.co.uk · 25 Jun 2026

Chemring wins $345m of contracts with US Dept of War for airborne countermeasures

Chemring Group (LSE:CHG) has secured up to $345 million of new US defence awards that will allow it to restart manufacturing at its previously discontinued Alloy Surfaces business in Philadelphia. The defence technology group said the US Department of War had awarded a modified five-year 'indefinite delivery, indefinite quantity' contract worth up to $300 million to produce pyrophoric airborne decoys.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.